期刊文献+

Toremifene诱导MCF-7/ADR细胞凋亡的研究 被引量:2

Toremifene Induced Apoptosis in MCF-7/ADR Cells
下载PDF
导出
摘要 目的 研究Toremifene体外诱导乳腺癌耐药细胞MCF-7/ADR凋亡和凋亡相关基因Fas、FasL、p53和Caspase-3表达的关系。方法 以不同浓度Toremifene(0.24μg/ml、2.4μg/ml、24μg/ml)诱导MCF-7/ADR细胞凋亡;以MTT法观察不同处理浓度的Toremifene对MCF-7/ADR细胞DNA合成活性的影响;以免疫组化检测Fas、FasL、p53和Caspase-3蛋白表达。结果 不同浓度Toremifene处理的MCF-7/ADR细胞出现DNA合成活性下降,抑制强度与浓度有关(P<0.05);Fas、FasL、p53和Caspase-3蛋白呈上调表达。结论 Toremifene能诱导细胞凋亡;增加Fas、FasL、p53和Caspase-3基因表达;并且与启动Caspase-3凋亡信号和p53直接介导的凋亡有关。 Objective To study the rektionship between apoptosis of MCF-7/ADR cells induced by Toremifene and the expression of Fas/FasL、P53 and Caspaae- 3 genes. Methods Different doses (0.24μg/ml、2.4μg/ml、24μg/ml) Toremifene were used to induce the apoptosis of MCF-7/ADR cells; MTT method was used for detecting DNA synthesizing activity. The expression of Fas/FasL、p53 and Caspase-3 protein was detected by immunohistochemical method. Results The MCF-7/ADR cells treated by different doses Toremifene demonstrated prominent morphologcial features and retardation of cellular growth accordingly, whose IR{ inhibiting rate) had relationship with doses ( P < 0.05) . The expression of Fas/FasL、 p53 and Caspase-3 protein was up-regulated. Conclusion Toremifene not only can induce the apoptosis of MCF-7/ADR cells and enhance the Fas/FasL、p53 and Caspase-3 genes but also is related to the start of conducting Caspase apoptosis message and p53 induced apoptosis.
出处 《实用肿瘤学杂志》 CAS 2003年第2期96-99,共4页 Practical Oncology Journal
  • 相关文献

参考文献5

  • 1潘启超胥彬主编.肿瘤药理学与化学治疗学[M].郑州:河南医科大学出版社,1999,9.730—73.
  • 2Vogel CL, Shemano I, Shoenfelder J, et al. Multicenter Phase Ⅱ efficacy in tamoxifen -refractory patients with advanced brast cancer .J Clin Oncol, 1993, 11:345.
  • 3Hayes DF,Vanzyl JA.Hacking A.et al.Randomized comparision of tamoxifen and two seperate doses of toremifene in postmenopausal patients with metastatic breast cancer.J Clin Oncol,1995,13(10):2556.
  • 4Boldin MP, Goncherov TM, Golstev YV, et al. Involvement of MACH,a novel morti/FADD- interaction protease, in Fss/Apo- 1 and TNF receptor induced cell death. Cell, 1996;85:803.
  • 5Boldin MP, Vsrfolomeev EE, Panoer Z. A novel protein that with the death domain of Fss/Apo- 1 contains a sequence motif related to the death domain. J Biol Chem, 1995;270:7795.

同被引文献22

  • 1Markus R,Werner S.Clinical trials of agents that reverses multidrug resistance[J].Cancer,1993,72:3553 ~ 3557.
  • 2Milla-Santos A,Milla L,Rallo L,et al.Phase randomized trial of toremifene vs tamoxifen in hormonxolependant advanced breast cancer[J].Brest Cancer Res,2001,65(2):119 ~124.
  • 3Kishino T,Watanabe M,Kimura M,et al.Anti-proliferative effect of toremifene and tamoxifen on estrogen receptor-lacking anaplastic thyroid carcinoma cell lines[J].Biol Pharm Bull,1997,20(12):1257 ~ 1260.
  • 4Baral E,Nagy E,Kangas L,et al.Immunotherapy of the sl2 -5murine lymphorma with natural killer cells and tamoxifen or toremifene[J].Anticancer Res,1997,17 (1 A):77 ~ 83.
  • 5Croxtall JD,Choudhury Q,White J O,et al.Tamxifen inhibits the release of arachidonic acid stimulated by thapsigargin in estrogen.receptor-negtive A549 cells[J].Biochim Biophys Acta,1997,1349(3):275 ~284.
  • 6Ito Y,Kobayashi T,Takeda T,et al..Expression of P21 (WAF/cipl) protein in clinical thyroid tissues[J].Br J Cancer,1996,74:1269.
  • 7Zhang W,Grasso L,McClain CD,et al.p53 -independent induction of WAF1/cipl in human leukemia cells is correlated with growth arrest accompanying monocyte macrophage differentiation[J].Cancer Res,1995,55:668.
  • 8Michieli P,Chedid M,Lin D,et al.Induction of WAF1/CIPI by a p53 -independent pathway[J].Cancer Res,1994,54:3391.
  • 9Saneki T,Mhashilkar A,Chada,et al.Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro[J].Gene Ther,2000,7 (23):2051 ~2057.
  • 10NCI Nary.Medical oncology branch cell line supplement[J].Cell Biochem Supple,1996,24:32 ~ 91.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部